CSIMarket
 
Elevance Health Inc   (NYSE: ELV)
Other Ticker:  
 
 
Price: $437.0000 $6.41 1.489%
Day's High: $437.89 Week Perf: 6.32 %
Day's Low: $ 430.74 30 Day Perf: 12.27 %
Volume (M): 848 52 Wk High: $ 567.26
Volume (M$): $ 370,449 52 Wk Avg: $474.17
Open: $433.28 52 Wk Low: $362.21



 Market Capitalization (Millions $) 101,762
 Shares Outstanding (Millions) 233
 Employees -
 Revenues (TTM) (Millions $) 177,011
 Net Income (TTM) (Millions $) 5,971
 Cash Flow (TTM) (Millions $) 1,828
 Capital Exp. (TTM) (Millions $) 1,256

Elevance Health Inc
Elevance Health Inc is a healthcare technology company that offers digital solutions to improve healthcare outcomes for patients and reduce administrative burdens for healthcare providers. The company offers a comprehensive suite of tools including payment automation, data analytics, patient engagement, and clinical decision support systems, among others.

Founded in 2015, Elevance Health has a mission to streamline the healthcare system by leveraging the latest in technology to overcome the challenges in the industry. They are focused on developing intelligent software solutions that bring automation, simplification, and precision to healthcare administration, making it easier for healthcare providers to deliver quality care to patients and achieve better outcomes.

One of the most notable solutions offered by Elevance Health is its payment automation platform, which helps healthcare providers to submit and process medical bills and insurance claims efficiently. The platform is designed to automate insurance verification, claim submission, and payment processing, reducing the potential for billing errors, improving payment turnaround times, and increasing revenue for healthcare providers.

Elevance Health also offers data analytic tools that allow healthcare providers to gain insights into patient populations, track performance against quality measures, and identify areas for improvement. The platform provides custom reports and dashboards, allowing healthcare providers to monitor key performance indicators and gain actionable insights that can inform decision-making.

The company's patient engagement solutions are also notable, as they leverage advanced technologies to improve communication between patients and healthcare providers. This includes patient portal solutions that allow patients to access their medical records, communicate with their doctors, and schedule appointments through a convenient online platform.

Overall, Elevance Health Inc is a healthcare technology company that is dedicated to improving healthcare outcomes through innovative software solutions. With a focus on payment automation, data analytics, patient engagement, and clinical decision support, Elevance Health is helping healthcare providers to streamline their workflows, reduce administrative burdens, and improve the quality of care they deliver to patients.


   Company Address: 220 Virginia Avenue Indianapolis 46204 IN
   Company Phone Number: 401-1577   Stock Exchange / Ticker: NYSE ELV


Customers Net Income fell by ELV's Customers Net Profit Margin fell to

-21.94 %

1.43 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AFL        2.56% 
CI        3.67% 
CNC        2.07% 
HUM        8.33% 
MOH   -2.72%    
UNH        4.67% 
• View Complete Report
   



Business Update

Elevance Health Appoints Nathan Rich as VP of Investor Relations, Reports Decrease in ROI Following Recent Financia...

Published Mon, Nov 4 2024 8:36 PM UTC

Elevance Health Inc. has made a notable change in its leadership by appointing Nathan Rich as the new Vice President of Investor Relations. This appointment comes at a pivotal time for the health care company, which has recently reported its financial performance for the third quarter of 2024.In its latest quarterly report, Elevance Health achieved a return on average invest...

Business Update

Elevance Healths Whole Health Index A Beacon of Improvement Amidst Market Challenges

Published Mon, Aug 12 2024 4:47 PM UTC

In the ever-evolving landscape of healthcare and health insurance, Elevance Health Inc. stands out not only for its market presence but also for its commitment to enhancing health outcomes through innovative metrics. The company s recent unveiling of its Whole Health Index serves as a pivotal moment, demonstrating potential opportunities for improving overall health, even in...

Dividend

Elevance Health Inc. Continues Strong Performance in Second Quarter and Eyes Future Growth Opportunities

Published Thu, Jul 18 2024 2:14 AM UTC

Elevance Health Reports Strong Second Quarter Results and Maintains Full-Year Outlook
Elevance Health, Inc. (NYSE: ELV) recently announced its second quarter 2024 results, demonstrating the success of its diversified business and strategic initiatives amidst a challenging industry landscape. The company remains focused on its mission to enhance human health and has prude...

Dividend

Elevance Health Soars with Strong Q2 Results - Stock Price Climbs Steadily

Published Wed, Jul 17 2024 12:57 PM UTC

Elevance Health Reports Strong Second Quarter Results - Stock Price on the Rise
Elevance Health, Inc. (NYSE: ELV) recently announced their second quarter 2024 results, showcasing the success of their diversified business strategy amidst a challenging industry landscape. The company s commitment to improving the health of humanity has driven their strategic initiatives, r...

Contract

Elevance Health and Clayton, Dubilier & Rice Join Forces to Transform Primary Care Delivery and Enhance Healthcare Experience

Published Mon, Apr 15 2024 11:00 AM UTC

Elevance Health, a leading healthcare company, has recently signed an agreement with Clayton, Dubilier & Rice (CD&R), a global private investment firm, to launch a strategic partnership aimed at advancing primary care delivery. This collaboration between the two influential companies seeks to accelerate innovation, enhance the healthcare experience, and ultimately improve he...







Elevance Health Inc's Segments
Product revenue    13.05 % of total Revenue
Service fees    4.48 % of total Revenue
Eliminations    -16.44 % of total Revenue
Health Benefits    84.86 % of total Revenue
Health Benefits Service fees    4.06 % of total Revenue
Total Product revenue    13.05 % of total Revenue
Total Service fees    0.45 % of total Revenue
CarelonRx    20.27 % of total Revenue
CarelonRx Product revenue    13.05 % of total Revenue
CarelonRx Service fees    0 % of total Revenue
Carelon Services    10.28 % of total Revenue
Carelon Services Service fees    0.45 % of total Revenue
Corporate Other    0.16 % of total Revenue
Corporate Other Service fees    -0.02 % of total Revenue
revenue - unaffiliated    99.14 % of total Revenue
revenue - unaffiliated Eliminations    -0.71 % of total Revenue
revenue - unaffiliated Health Benefits    84.86 % of total Revenue
revenue - unaffiliated Total    15.01 % of total Revenue
revenue - unaffiliated CarelonRx    13.06 % of total Revenue
revenue - unaffiliated Carelon Services    1.95 % of total Revenue
revenue - unaffiliated Corporate Other    -0.02 % of total Revenue
revenue - affiliated Eliminations    -15.73 % of total Revenue
revenue - affiliated Total    15.54 % of total Revenue
revenue - affiliated CarelonRx    7.21 % of total Revenue
revenue - affiliated Carelon Services    8.33 % of total Revenue
revenue - affiliated Corporate Other    0.19 % of total Revenue

  Elevance Health Inc Outlook

On June 27 2024 the Elevance Health Inc provided following guidance



Elevance Health Inc. (NYSE: ELV) anticipates releasing its financial results for the second quarter of 2024 on July 17th, 2024, at 6:00 a.m. EDT. Following the release, a conference call is scheduled to take place at 8:30 a.m. EDT on the same day. During the call, management will discuss the financial results and provide insights into the company's outlook moving forward.

To join the conference call, participants are required to dial in at least 15 minutes prior to the scheduled start time using the following numbers: 888-947-9963 for domestic participants with the access code 3972058, and 312-470-0178 for international participants with the same access code 3972058.

Investors, s, and o...





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com